JP2013517886A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013517886A5 JP2013517886A5 JP2012550567A JP2012550567A JP2013517886A5 JP 2013517886 A5 JP2013517886 A5 JP 2013517886A5 JP 2012550567 A JP2012550567 A JP 2012550567A JP 2012550567 A JP2012550567 A JP 2012550567A JP 2013517886 A5 JP2013517886 A5 JP 2013517886A5
- Authority
- JP
- Japan
- Prior art keywords
- fibrinogen
- solid
- liquid
- returned
- original
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108010049003 Fibrinogen Proteins 0.000 description 12
- 102000008946 Fibrinogen Human genes 0.000 description 12
- 229940012952 fibrinogen Drugs 0.000 description 12
- 239000007788 liquid Substances 0.000 description 9
- 239000007787 solid Substances 0.000 description 8
- 108010080379 Fibrin Tissue Adhesive Proteins 0.000 description 5
- 239000000243 solution Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 108090000190 Thrombin Proteins 0.000 description 3
- 239000003937 drug carrier Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 229960004072 thrombin Drugs 0.000 description 3
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 239000008055 phosphate buffer solution Substances 0.000 description 2
- 108010073385 Fibrin Proteins 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000012263 liquid product Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 1
- 239000003998 snake venom Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US29912710P | 2010-01-28 | 2010-01-28 | |
| US61/299,127 | 2010-01-28 | ||
| PCT/IL2011/000092 WO2011092694A2 (en) | 2010-01-28 | 2011-01-27 | Method for improved fibrin sealing |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013517886A JP2013517886A (ja) | 2013-05-20 |
| JP2013517886A5 true JP2013517886A5 (enExample) | 2015-11-05 |
| JP5859461B2 JP5859461B2 (ja) | 2016-02-10 |
Family
ID=43923707
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012550567A Expired - Fee Related JP5859461B2 (ja) | 2010-01-28 | 2011-01-27 | フィブリンのシール性を向上させるための方法 |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US8962033B2 (enExample) |
| EP (1) | EP2528631B1 (enExample) |
| JP (1) | JP5859461B2 (enExample) |
| KR (1) | KR101786786B1 (enExample) |
| CN (1) | CN102791299B (enExample) |
| AU (1) | AU2011210356B2 (enExample) |
| BR (1) | BR112012018970B1 (enExample) |
| CA (1) | CA2787883C (enExample) |
| DK (1) | DK2528631T3 (enExample) |
| ES (1) | ES2513516T3 (enExample) |
| MX (1) | MX2012008845A (enExample) |
| RU (1) | RU2556960C2 (enExample) |
| WO (1) | WO2011092694A2 (enExample) |
| ZA (1) | ZA201206438B (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL234246A0 (en) * | 2014-08-21 | 2014-11-30 | Omrix Biopharmaceuticals Ltd | Stabilized thrombin |
| CA2960589A1 (en) | 2014-09-11 | 2016-03-17 | Omrix Biopharmaceuticals Ltd. | Addition to a medical applicator |
| US9801983B2 (en) * | 2014-12-18 | 2017-10-31 | Cook Medical Technologies Llc | Medical devices for delivering a bioactive to a point of treatment and methods of making medical devices |
| US20170128617A1 (en) * | 2015-11-11 | 2017-05-11 | Ethicon, Inc. | Sealant formulation and uses thereof |
| IL247821A0 (en) | 2016-09-14 | 2017-01-31 | Omrix Biopharmaceuticals Ltd | Adhesive preparations and their use |
| US12115356B2 (en) * | 2019-03-06 | 2024-10-15 | Gambro Lundia Ab | Device and method for the delivery of a thrombin activated fibrin sealant |
| KR102093839B1 (ko) * | 2019-05-28 | 2020-05-04 | (주)다림티센 | 지혈용 조성물 및 이를 포함하는 용기 |
| US11666682B2 (en) * | 2020-08-31 | 2023-06-06 | Ethicon, Inc. | Method of stopping CSF leaks and apparatus therefor |
Family Cites Families (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1776489A (en) | 1928-03-12 | 1930-09-23 | Carolus M Cobb | Powder distributor |
| ATE20824T1 (de) * | 1981-06-25 | 1986-08-15 | Serapharm Gmbh & Co Kg | Angereichertes plasmaderivat zur unterstuetzung von wundverschluss und wundheilung. |
| AT379311B (de) | 1984-03-29 | 1985-12-27 | Immuno Ag | Vorrichtung zur applikation eines gewebeklebstoffes |
| DE3725552A1 (de) | 1987-08-01 | 1989-02-09 | Hoechst Ag | Spruehkopf zum applizieren eines mehrkomponentenmaterials mittels gas |
| DE3843126C3 (de) | 1988-12-22 | 1994-10-06 | Octapharma Ag | Verfahren zur Herstellung eines hochreinen Thrombinkonzentrates |
| US5116315A (en) | 1989-10-03 | 1992-05-26 | Hemaedics, Inc. | Biological syringe system |
| US7208179B1 (en) | 1990-11-27 | 2007-04-24 | The American National Red Cross | Methods for treating disease and forming a supplemented fibrin matrix |
| US5690675A (en) | 1991-02-13 | 1997-11-25 | Fusion Medical Technologies, Inc. | Methods for sealing of staples and other fasteners in tissue |
| US5792835A (en) | 1991-09-05 | 1998-08-11 | Baxter International Inc. | Method of preparing a topical fibrinogen complex |
| WO1993005822A1 (en) | 1991-09-27 | 1993-04-01 | Octapharma Ag | Tissue glue prepared by using cryoprecipitate |
| WO1994007420A1 (fr) | 1992-09-26 | 1994-04-14 | Juridical Foundation The Chemo-Sero-Therapeutic Research Institute | Applicateur d'adhesif destine a des tissus |
| CN1088117A (zh) * | 1992-12-14 | 1994-06-22 | 白求恩医科大学第二临床学院 | 高效生物胶 |
| US5330974A (en) * | 1993-03-01 | 1994-07-19 | Fibratek, Inc. | Therapeutic fibrinogen compositions |
| AT400304B (de) | 1994-02-28 | 1995-12-27 | Immuno Ag | Vorrichtung zur applikation eines mehrkomponenten-gewebeklebstoffes |
| WO1996022115A1 (en) | 1995-01-16 | 1996-07-25 | Baxter International Inc. | Self-supporting sheet-like material of cross-linked fibrin for preventing post operative adhesions |
| AU708165B2 (en) | 1995-06-06 | 1999-07-29 | Interpore International Inc. | Wound sealant preparation and application device and method |
| DE19521324C1 (de) | 1995-06-12 | 1996-10-31 | Immuno Ag | Gewebeklebstoff und Verwendung desselben als Hämostyptikum |
| DE19617369A1 (de) | 1996-04-30 | 1997-11-06 | Immuno Ag | Lagerstabile Fibrinogen-Präparate |
| US6121232A (en) | 1997-01-31 | 2000-09-19 | Omrix Biopharmaceuticals Sa | Stabilized mixture comprising fibrinogen |
| EP0856317A1 (en) | 1997-01-31 | 1998-08-05 | Omrix Biopharmaceuticals S.A. | A stabilized mixture comprising fibrinogen |
| US6461361B1 (en) | 1998-05-01 | 2002-10-08 | Baxter International Inc. | Gas-driven spraying of mixed sealant agents |
| DE19849589C1 (de) | 1998-10-27 | 2000-06-15 | Glatt Process Technology Gmbh | Fibrin-Gewebekleber-Formulierung und Verfahren zu dessen Herstellung |
| ATA49899A (de) | 1999-03-19 | 2002-06-15 | Immuno Ag | Verfahren und vorrichtung zum mischen von komponenten |
| US20050049178A1 (en) * | 1999-07-06 | 2005-03-03 | Oberschwabenklinik Gmbh | Agent for the occlusion of blood vessels |
| US6802822B1 (en) | 2000-03-31 | 2004-10-12 | 3M Innovative Properties Company | Dispenser for an adhesive tissue sealant having a flexible link |
| US6585696B2 (en) | 2000-12-22 | 2003-07-01 | Baxter International, Inc. | Method and apparatus for applying a medically useful multiple component material |
| BRPI0206708B8 (pt) | 2001-01-25 | 2021-06-22 | Nycomed Pharma As | composição sólida, composição para hemostasia, vedação de tecido e colagem de tecido, e, usos de um veículo de colágeno |
| PL205685B1 (pl) | 2001-05-21 | 2010-05-31 | Omrix Biopharm Sa | Sposób in vitro usuwania lub wyodrębniania plazminogenu lub plazminy w obecności fibrynogenu, stałe podłoże powinowactwa do oczyszczania mieszaniny zawierającej fibrynogen i plazminę i/lub plazminogen oraz krioprecypitat |
| EP1742692A4 (en) | 2004-03-17 | 2012-06-27 | Genzyme Corp | ANTI-ADHERENCE SPRAY |
| DE602005013301D1 (de) | 2005-11-22 | 2009-04-23 | Omrix Biopharm Sa | Applikatorvorrichtung zum aufbringen einer mehrkomponenten-flüssigkeit |
| US20080033332A1 (en) | 2006-08-04 | 2008-02-07 | Macphee Martin | Solid dressing for treating wounded tissue |
| ES2649755T3 (es) | 2006-11-02 | 2018-01-15 | Omrix Biopharmaceuticals Ltd. | Procedimiento de micronización |
| EP2011524A1 (en) | 2007-07-02 | 2009-01-07 | Omrix Biopharmaceuticals Ltd. | Fibrin glue with a visualization agent |
| JP5805542B2 (ja) | 2009-02-20 | 2015-11-04 | オムリックス・バイオファーマシューティカルズ・リミテッドＯｍｒｉｘ Ｂｉｏｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｌｔｄ． | 少なくとも２成分の薬物を投与する装置 |
-
2011
- 2011-01-27 MX MX2012008845A patent/MX2012008845A/es active IP Right Grant
- 2011-01-27 RU RU2012136648/15A patent/RU2556960C2/ru not_active IP Right Cessation
- 2011-01-27 DK DK11706629T patent/DK2528631T3/da active
- 2011-01-27 CN CN201180007775.6A patent/CN102791299B/zh not_active Expired - Fee Related
- 2011-01-27 WO PCT/IL2011/000092 patent/WO2011092694A2/en not_active Ceased
- 2011-01-27 AU AU2011210356A patent/AU2011210356B2/en not_active Ceased
- 2011-01-27 ES ES11706629.0T patent/ES2513516T3/es active Active
- 2011-01-27 KR KR1020127022330A patent/KR101786786B1/ko not_active Expired - Fee Related
- 2011-01-27 JP JP2012550567A patent/JP5859461B2/ja not_active Expired - Fee Related
- 2011-01-27 CA CA2787883A patent/CA2787883C/en not_active Expired - Fee Related
- 2011-01-27 BR BR112012018970A patent/BR112012018970B1/pt not_active IP Right Cessation
- 2011-01-27 EP EP20110706629 patent/EP2528631B1/en not_active Not-in-force
- 2011-01-28 US US13/015,999 patent/US8962033B2/en active Active
-
2012
- 2012-08-27 ZA ZA2012/06438A patent/ZA201206438B/en unknown
-
2015
- 2015-01-07 US US14/591,265 patent/US9302026B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013517886A5 (enExample) | ||
| EA201892446A1 (ru) | Фармацевтическая композиция | |
| JP2014139229A5 (enExample) | ||
| MY197672A (en) | Room temperature stable lyophilized protein | |
| BR112013003244A2 (pt) | composição seca estabilizante de armazenamento para materiais biológicos | |
| EA201790989A1 (ru) | Стабильный препарат раствора белка, содержащего анти-vegf антитело в высокой концентрации | |
| MY178686A (en) | Stabilizing composition for biological materials | |
| EA201591657A1 (ru) | Порошковая композиция | |
| JP2008509924A5 (enExample) | ||
| JP2016520075A5 (enExample) | ||
| AR115581A1 (es) | Métodos de preparación de composiciones de aminoácidos | |
| JP2015508403A5 (enExample) | ||
| JP2018184425A (ja) | 溶剤／界面活性剤処理された血漿（ｓ／ｄ血漿）を含む製剤及びその使用 | |
| BR112012010400A2 (pt) | composição co-processada, processo para preparar uma composição útil como um excipiente farmacêutico, formulação de granulado ou comprimido, método, e, forma de dosagem sólida | |
| RU2019111152A (ru) | Новый способ стабилизации биофармацевтического лекарственного продукта при производстве | |
| CA2868862C (en) | Method and apparatus for preparing single donor thrombin serum | |
| RU2014124143A (ru) | Стабильная композиция антитела, специфически связывающегося с her2 рецепторами, и способ ее получения | |
| CN105288652A (zh) | 一种超氧化物歧化酶微囊粉及其配制方法 | |
| RU2012125626A (ru) | Композиция имплантата для регенерации нервной ткани, способ ее получения и ее применение | |
| RU2015135637A (ru) | Способ получения и состав для получения сухих лиофилизированных форм антоцианов и бетацианинов | |
| RU2008152546A (ru) | Способ очистки загрязненного грунта | |
| JP2019163212A (ja) | スフェロイド形成促進剤の濃縮方法および精製方法。 | |
| UA108527C2 (uk) | Спосіб одержання водорозчинної лікарської форми антибіотика з групи рифаміцинів | |
| RU2019109927A (ru) | Состав для внутривенных инъекций, предназначенный для повышения иммунитета | |
| Stief | Tranexamic acid might stop severe bleeding by intrinsic generation of thrombin |